HealthNewsAPI
FDA approves new higher-dose version of Wegovy shots - AP News
Overview
The FDA approved a higher-dose version of Wegovy (semaglutide), which may help users lose more weight and maintain reductions but also sharpens concerns about side effects and long-term management. New evidence that variation in two gut-hormone genes affects GLP-1 response indicates that not all patients will benefit equally from higher doses, supporting the need for individualized risk–benefit discussions and monitoring.
Entities
ORGAP NewsORGFDAORGU.S. Food and Drug AdministrationORGNovo NordiskUnited States
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 8 · Connections: 7
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.